<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="401">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 27, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00497835</url>
  </required_header>
  <id_info>
    <org_study_id>Biolert LTD</org_study_id>
    <nct_id>NCT00497835</nct_id>
  </id_info>
  <brief_title>Study of Algorithm for Epilepsy Alert Device</brief_title>
  <official_title>Epilepsy Alert Device - Epilert Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biolert</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biolert</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An accelerometer with transmitting ability is worn on the wrist. Data of movements during
      seizures will be analyzed to upgrade algorithm that will identify seizures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing Video-EEG telemetry will wear movement sensor on their wrist. The sensor
      will transmit continuous data to a laptop. Seizures' data (tonic or clonic) will be analyzed
      and transformed into an algorithm (up-graded existing preliminary algorithm).

      In the second phase the algorithm will need to identify seizure events within one minute of
      the onset.

      Both specificity (&quot;false positive&quot;) and sensitivity (&quot;false negative) will be than
      calculated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Motor Seizures</condition>
  <biospec_descr>
    <textblock>
      no Biospecimen
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to Video-LTM Unit with motor seizures.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing Long Term Monitoring for motor seizures

        Exclusion Criteria:

          -  Invasive recording

          -  Psychogenic seizures
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Swetlana Kiperwasser, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <removed_countries>
    <country>Israel</country>
  </removed_countries>
  <verification_date>July 2007</verification_date>
  <lastchanged_date>June 14, 2011</lastchanged_date>
  <firstreceived_date>July 6, 2007</firstreceived_date>
  <responsible_party>
    <name_title>Prof. Uri Kramer. Chief scientist</name_title>
    <organization>Biolert LTD</organization>
  </responsible_party>
  <keyword>motor seizures</keyword>
  <keyword>accelerometer</keyword>
  <keyword>algorithm</keyword>
  <keyword>detection</keyword>
  <keyword>alert</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
